(NEW YORK)–Fruit Street Health, a digital health and telehealth startup focused on delivering the CDC’s Diabetes Prevention Program and other chronic disease prevention programs, announced it has raised an additional $3 million since its last funding round a year ago on June 1st, 2016.
This additional equity raise now brings Fruit Street’s total funding to $8.4 million, which brings the total number of physicians who have invested in Fruit Street to over 200. The lead investor was Dr. Jeremy Tucker who is a senior emergency medicine physician on the board of directors of Fruit Street.
Fruit Street’s digital health platform enables healthcare providers such as physicians and registered dietitians to conduct HIPAA compliant video consultations with their patients and also monitor their health, diet, and lifestyle using medical devices, wearable devices, and the Fruit Street mobile application for dietary tracking. Devices such as wireless scales, Fitbit trackers, blood pressure cuffs, and glucometers are integrated into the platform. The Fruit Street “Instagram style” mobile app encourages patients to take photos of their food which are transmitted to their dietitians for feedback.
Fruit Street licenses its digital health platform to healthcare providers, but also uses its digital health platform to deliver the Diabetes Prevention Program (DPP) to commercial health plan members using its own staff of registered dietitians. The National DPP is an evidence-based lifestyle change program which has been demonstrated to delay or prevent the development of type 2 diabetes among people at high risk.
The DPP, conducted by the Diabetes Prevention Program Research Group, was a major multicenter clinical research study published in 2002 with 3,234 participants who were overweight and had prediabetes, aimed at discovering whether modest weight loss through dietary changes and increased physical activity or treatment with the oral diabetes drug metformin (Glucophase) was more effective at preventing or delaying type 2 diabetes. The DPP showed that people at risk for developing diabetes can prevent or delay the onset of diabetes by losing a modest amount of weight through diet and exercise. DPP participants in the lifestyle intervention group reduced their risk of developing diabetes by 58 percent during the study. Lifestyle changes worked particularly well for participants aged 60 and older, reducing their risk by 71 percent. Participants taking metformin reduced their risk of developing diabetes by 31 percent which was less dramatic than the lifestyle modification group. The researchers published their findings in the February 7, 2002, issue of the New England Journal of Medicine (“Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin”).
Fruit Street has raised this additional capital to fund additional software development through its joint venture agreement with VSee.com, and to hire more dietitians to deliver the diabetes prevention program to commercial health plans.
About Fruit Street
Fruit Street is a telemedicine software product that is licensed to healthcare professionals which allows them to conduct HIPAA compliant video consultations with their patients and monitor their patients’ health, diet, and lifestyle using medical and wearable devices. http://www.fruitstreet.com
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was not compensated for ongoing media advisory services, and thus should be considered a possible conflict of interest when reviewing this report and information. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities.
- FDA Guidance on CBD Infused Products May Signal Bottom for Stock Sector - August 17, 2019
- Vectorspace AI (VXV) and ESTC Discuss Visualizing Alpha Utilizing Datasets and Canvas - August 8, 2019
- Vectorspace (VXV) Crypto Coin Big Uses for Quant Hedge Funds - July 1, 2019
- BioHemp (BKIT) Added to Watch List as CBD Distribution Play - June 28, 2019
- Hammer Fiber (HMMR) Moves Towards Profit in Earnings Report - June 27, 2019
- Maybe It’s Time to Automate Politicians to History Bin Using AI - April 21, 2019
- Biopharma Growth Opportunities in China, Thurs. April 4th in NYC - April 2, 2019
- IPO Schedule This Week: MITO KLDO CSTX PSTX - February 4, 2019
- IPO Investor Watch: ANCN HKIT HOTH - February 2, 2019
- CIIX Reports +43% Revenue Growth, CBD Sales Increase 8x over 2018 - January 23, 2019